Why the study?
Does extracorporeal life support stabilize pediatric patients presenting with life-threatening arrhythmias and Brugada syndrome?
Does extracorporeal life support stabilize pediatric patients presenting with life-threatening arrhythmias and Brugada syndrome?
Extracorporeal life support can serve as a lifesaving bridge to diagnosis and definitive therapy in pediatric patients presenting with unexplained cardiac arrest due to arrhythmias such as Brugada syndrome.
Supports ECLS bridge in rare pediatric Brugada arrest; hypothesis-generating, needs prospective data before adoption.
We describe the use of extracorporeal cardiopulmonary resuscitation (E-CPR) to transiently stabilize a 3-month-old patient who presented with ventricular tachyarrhythmias leading to spontaneous cardiac arrest. The patient required 4 days of extracorporeal life support (ECLS) where he was diagnosed with probable Brugada syndrome (BS). The patient was discharged home in stable condition after implantable cardioverter defibrillator placement. This case highlights the importance of early transfer to extracorporeal membrane oxygenation (ECMO) center in the setting of unexplained cardiac arrhythmia in a pediatric patient. BS is an autosomal dominant genetic disorder with variable expression characterized by abnormal findings on electrocardiogram (ECG) in conjunction with an increased risk of ventricular tachyarrhythmias and sudden cardiac arrest (SCA). Early management is critical and early consideration to transfer to an institution where extracorporeal life support (ECLS/ECMO) is present to support the patient while further diagnostic work up is in progress is lifesaving.
No takes yet. Share an insight, caveat, or question.
Beshish et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: